With the body contouring market projected to nearly double by 2035, non-invasive treatments are driving much of that growth. This surge in preference is largely fueled by the rise of prescription weight loss medications, which offer a non-surgical, convenient way to lose weight—especially when paired with exercise and a healthy diet. These medications have reshaped the narrative around rapid weight loss: it's no longer just about appearance, but about feeling better.
As tailored non-invasive solutions continue to be sought out following GLP-1 use, lasers—commonly associated with hair removal and skin rejuvenation, are on the rise, including laser lipolysis using heat and low-level laser therapy, using cold energy, to target fat calls and sculpt areas of the body.
This article is only available to registered users.
Log In to View the Full Article
With the body contouring market projected to nearly double by 2035, non-invasive treatments are driving much of that growth. This surge in preference is largely fueled by the rise of prescription weight loss medications, which offer a non-surgical, convenient way to lose weight—especially when paired with exercise and a healthy diet. These medications have reshaped the narrative around rapid weight loss: it's no longer just about appearance, but about feeling better.
As tailored non-invasive solutions continue to be sought out following GLP-1 use, lasers—commonly associated with hair removal and skin rejuvenation, are on the rise, including laser lipolysis using heat and low-level laser therapy, using cold energy, to target fat calls and sculpt areas of the body.
Erchonia, a laser technology company, notes this shift in a Sept. 3 press release, acknowledging the weight loss industry's natural shift toward safe and sustainable fat loss solutions that are non-invasive to balance the effects of weight loss medication. The process of low-level laser therapy, the release states, involves non-thermal light energy to create temporary pores in fat cells, allowing lipids to be released and naturally eliminated by the body.
Though 44% of Gen Z consumers in the U.S. report struggling to stay motivated to exercise [1], the growing accessibility of prescription weight loss medications has made them a preferred alternative, ranking just behind physical activity since 2023. While these medications effectively support fat loss, they also introduce new aesthetic challenges, such as skin laxity, facial volume loss and a prematurely aged appearance [2].
This is where non-invasive body contouring steps in as a complementary solution for many patients. Unlike surgical procedures, these treatments offer a gentler way to refine the body’s appearance following rapid weight loss. According to Future Market Insights [3], the body contouring market is expected to reach $8.9 billion in 2025 and grow to $17.4 billion by 2035—with non-invasive treatments leading the category at 43%. This growth reflects the increasing demand for treatments that are as effective and targeted as surgery, but with less downtime and lower risk.
While lasers have traditionally been associated with skin rejuvenation and hair removal, personalized treatment is becoming a key priority for patients seeking solutions tailored to their unique goals. According to Erchonia, providers are increasingly turning to laser therapy as a way to tailor treatment after rapid weight loss, like low-level laser therapy, due to its quick sessions, lack of recovery time and repeatable nature.
References:
1- https://www.mckinsey.com/industries/consumer-packaged-goods/our-insights/future-of-wellness-trends
2-https://www.medestheticsmag.com/home/article/22947292/new-report-finds-consumers-prioritize-aesthetic-treatments-above-dining-fashion
3-https://www.futuremarketinsights.com/reports/body-contouring-market
